1. Home
  2. BNZI vs LEXX Comparison

BNZI vs LEXX Comparison

Compare BNZI & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNZI
  • LEXX
  • Stock Information
  • Founded
  • BNZI 2016
  • LEXX 2004
  • Country
  • BNZI United States
  • LEXX Canada
  • Employees
  • BNZI N/A
  • LEXX N/A
  • Industry
  • BNZI
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNZI
  • LEXX Health Care
  • Exchange
  • BNZI Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • BNZI 16.5M
  • LEXX 19.6M
  • IPO Year
  • BNZI N/A
  • LEXX N/A
  • Fundamental
  • Price
  • BNZI $0.62
  • LEXX $0.86
  • Analyst Decision
  • BNZI Strong Buy
  • LEXX Strong Buy
  • Analyst Count
  • BNZI 1
  • LEXX 1
  • Target Price
  • BNZI $24.00
  • LEXX $5.00
  • AVG Volume (30 Days)
  • BNZI 4.1M
  • LEXX 145.7K
  • Earning Date
  • BNZI 08-13-2025
  • LEXX 07-15-2025
  • Dividend Yield
  • BNZI N/A
  • LEXX N/A
  • EPS Growth
  • BNZI N/A
  • LEXX N/A
  • EPS
  • BNZI N/A
  • LEXX N/A
  • Revenue
  • BNZI $6,827,490.00
  • LEXX $525,923.00
  • Revenue This Year
  • BNZI $570.18
  • LEXX $0.62
  • Revenue Next Year
  • BNZI $34.44
  • LEXX $14.19
  • P/E Ratio
  • BNZI N/A
  • LEXX N/A
  • Revenue Growth
  • BNZI 52.95
  • LEXX 29.95
  • 52 Week Low
  • BNZI $0.54
  • LEXX $0.82
  • 52 Week High
  • BNZI $11.20
  • LEXX $4.38
  • Technical
  • Relative Strength Index (RSI)
  • BNZI 38.68
  • LEXX 33.73
  • Support Level
  • BNZI $0.54
  • LEXX $0.82
  • Resistance Level
  • BNZI $0.74
  • LEXX $1.05
  • Average True Range (ATR)
  • BNZI 0.10
  • LEXX 0.06
  • MACD
  • BNZI 0.00
  • LEXX -0.01
  • Stochastic Oscillator
  • BNZI 20.94
  • LEXX 15.44

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: